The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis. 1997

M M Maheshwar, and J P Cheadle, and A C Jones, and J Myring, and A E Fryer, and P C Harris, and J R Sampson
Institute of Medical Genetics, University of Wales College of Medicine, Cardiff, UK.

Tuberous sclerosis is an autosomal dominant trait in which the dysregulation of cellular proliferation and differentiation results in the development of hamartomatous growths in many organs. The TSC2 gene is one of two genes determining tuberous sclerosis. Inactivating germline mutations of TSC2 in patients with tuberous sclerosis and somatic loss of heterozygosity at the TSC2 locus in the associated hamartomas indicate that TSC2 functions as a tumour suppressor gene and that loss of function is critical to expression of the tuberous sclerosis phenotype. The TSC2 product, tuberin, has a region of homology with the GTPase activating protein rap1GAP and stimulates the GTPase activity of rap1a and rab5a in vitro. Here we show that the region of homology between tuberin and human rap1GAP and the murine GAP mSpa1 is more extensive than previously reported and spans approximately 160 amino acid residues encoded within exons 34-38 of the TSC2 gene. Single strand conformation polymorphism analysis of these exons in 173 unrelated patients with tuberous sclerosis and direct sequencing of variant conformers together with study of additional family members enabled characterisation of disease associated mutations in 14 cases. Missense mutations, which occurred in exons 36, 37 and 38 were identified in eight cases, four of whom shared the same recurrent change P1675L. Each of the five different missense mutations identified was shown to occur de novo in at least one sporadic case of tuberous sclerosis. The high proportion of missense mutations detected in the region of the TSC2 gene encoding the GAP-related domain supports its key role in the regulation of cellular growth.

UI MeSH Term Description Entries
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D012097 Repressor Proteins Proteins which maintain the transcriptional quiescence of specific GENES or OPERONS. Classical repressor proteins are DNA-binding proteins that are normally bound to the OPERATOR REGION of an operon, or the ENHANCER SEQUENCES of a gene until a signal occurs that causes their release. Repressor Molecules,Transcriptional Silencing Factors,Proteins, Repressor,Silencing Factors, Transcriptional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077005 Tuberous Sclerosis Complex 2 Protein An intracellular signaling and tumor suppressor protein that forms a complex with TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN (TSC1) and other signaling factors to negatively regulate MTORC1 and affect cell growth and proliferation. It can also function as GTPASE-ACTIVATING PROTEIN (GAP) for RHEB GTPASE to activate mTORC1 independent of its role in the complex. Structurally, it interacts with TSC1 through its N-terminus, which also contains a leucine zipper and coiled-coil region. It also has multiple phosphorylation sites for different cell signaling kinases, a central coiled-coil region, a C-terminal GAP domain and CALMODULIN binding domain. Mutations in the TSC2 gene are associated with TUBEROUS SCLEROSIS. Tuberin,Tuberous Sclerosis 2 Protein

Related Publications

M M Maheshwar, and J P Cheadle, and A C Jones, and J Myring, and A E Fryer, and P C Harris, and J R Sampson
January 1998, Human mutation,
M M Maheshwar, and J P Cheadle, and A C Jones, and J Myring, and A E Fryer, and P C Harris, and J R Sampson
May 2004, Journal of medical genetics,
M M Maheshwar, and J P Cheadle, and A C Jones, and J Myring, and A E Fryer, and P C Harris, and J R Sampson
December 2001, Human molecular genetics,
M M Maheshwar, and J P Cheadle, and A C Jones, and J Myring, and A E Fryer, and P C Harris, and J R Sampson
October 2001, Journal of cutaneous pathology,
M M Maheshwar, and J P Cheadle, and A C Jones, and J Myring, and A E Fryer, and P C Harris, and J R Sampson
January 2003, The Journal of biological chemistry,
M M Maheshwar, and J P Cheadle, and A C Jones, and J Myring, and A E Fryer, and P C Harris, and J R Sampson
March 1997, The Journal of biological chemistry,
M M Maheshwar, and J P Cheadle, and A C Jones, and J Myring, and A E Fryer, and P C Harris, and J R Sampson
December 2000, Oncogene,
M M Maheshwar, and J P Cheadle, and A C Jones, and J Myring, and A E Fryer, and P C Harris, and J R Sampson
July 1995, The Journal of biological chemistry,
M M Maheshwar, and J P Cheadle, and A C Jones, and J Myring, and A E Fryer, and P C Harris, and J R Sampson
September 2009, European journal of human genetics : EJHG,
M M Maheshwar, and J P Cheadle, and A C Jones, and J Myring, and A E Fryer, and P C Harris, and J R Sampson
March 2009, European journal of human genetics : EJHG,
Copied contents to your clipboard!